Ticker: CGON

Company Overview: CG Oncology, Inc. (NASDAQ: CGON) is a late-stage clinical biopharmaceutical company focused on developing its product candidate, cretostimogene grenadenorepvec, for bladder cancer treatment. The company is at a clinical stage and has not yet projected significant revenues withou...